State moves to curb over-the-counter sale of erectile dysfunction drugs

State Department for Public Health and Professional Standards Principal Secretary Mary Muthoni/HANDOUT

The government has announced measures to curb over-the-counter sale of prescription medication used to treat erectile dysfunction (ED), popularly known as 'blue pills.'

State Department for Public Health and Professional Standards Principal Secretary Mary Muthoni said the drugs are strictly a prescription-only medicine and not over-the-counter products.

She noted that they are also used to treat pulmonary arterial hypertension (PAH).

“When taken with other medicines-especially nitrates or certain blood pressure and heart medicines- it can cause dangerous interactions and increase the risk of life-threatening events such as heart attack and stroke; patients should consult a doctor or pharmacist before use,” Muthoni said in a statement posted on X.

Muthoni noted that the ministry is implementing a monitoring system requiring wholesalers to document and report sales of prescription medicines to retailers.

She further said the ministry is conducting audits and inspections of pharmacies by reviewing prescription records for controlled dispensing and educating consumers on the risks and consequences of using prescription-only medicines without a valid prescription.

The widespread availability of prescription medicines over the counter has become a growing public health concern in Kenya, exposing millions of people to serious health risks.

Drugs that are legally meant to be dispensed only after medical evaluation are often sold freely in pharmacies, chemist shops and informal outlets, allowing patients to self-diagnose and self-medicate without professional guidance.

This practice increases the likelihood of incorrect dosing, harmful drug interactions and delayed diagnosis of underlying conditions.

One of the most troubling aspects of the problem is the misuse of medicines intended to treat chronic or life-threatening conditions, including antibiotics, erectile dysfunction drugs and cardiovascular medication.

Without proper screening, individuals may unknowingly take drugs that worsen existing health problems such as heart disease, liver conditions or high blood pressure.

In some cases, symptoms that require urgent medical attention are masked, giving patients a false sense of improvement while the disease progresses untreated.

The over-the-counter sale of prescription drugs has also contributed to broader systemic challenges, notably the rise of antimicrobial resistance.

Easy access to antibiotics encourages incomplete courses, inappropriate use and sharing of medication, all of which fuel drug-resistant infections that are harder and more expensive to treat.

This places an additional burden on an already stretched healthcare system and undermines national efforts to safeguard the effectiveness of essential medicines.

Regulatory gaps, weak enforcement and economic pressures on both sellers and consumers have allowed the practice to persist.

For many Kenyans, the high cost of consultations, long queues in public hospitals and limited access to healthcare in rural areas make pharmacies the first and often only point of care.